The pharmaceutical industry is a key partner in Europe’s fight against disease, developing new treatments and cures for patients across Europe. It is imperative that Europe remains a competitive destination for medical research and development by maintaining, sustaining and developing a predictable, robust regulatory and innovation-supportive incentives environment.

In the first half of 2021, 336,598 Twenty-Foot Equivalent Units (TEUs) were transported along the Eurasian railway transit route in the China—Europe—China direction, which is 50% more than in the first half of 2020.